Search for: "State v. Lilly" Results 361 - 380 of 910
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
10 Jun 2014, 7:44 pm
 In this post, guest contributor Paul England (Taylor Wessing LLP) explains the legal issues and their consequences:UKIPO -- a 'court' for the purposes of the Brussels I Regulation Some courts look like this ...With Actavis v Eli Lilly [noted on the IPKat here] still fresh in our minds, and amendments to the Brussels I Regulation (recast) progressing through the European Parliament in preparation for the Unified Patent Court, jurisdictional matters are a hot… [read post]
2 Jun 2014, 4:43 am
  Louisiana joined the fray late in Sergeants Benevolent Association Health & Welfare Fund v. [read post]
22 May 2014, 3:58 pm by Aaron Barkoff
 Speakers include in-house counsel from Eli Lilly, Mylan, Sandoz, Amgen, AbbVie, Momenta, J&J, and Actavis. [read post]
16 May 2014, 8:58 am
 So this moggy is enormously grateful to his EIP colleague Matthew Jones, for preparing a report of this case, which came out at the same time as the Actavis v Lilly decision. [read post]
15 May 2014, 11:40 am
 On the principle of the matter, he stated at 111:In my judgment this reasoning [from Rohm & Haas] is persuasive, and it is supported by the subsequent judgment of the Court of Appeal in Virgin v Premium. [read post]
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]
8 Apr 2014, 1:17 pm by Dr. Shezad Malik
Takeda and Lilly face hundreds more claims over Actos in state courts including Nevada and Illinois. [read post]